CD44 and breast carcinoma: Accordingly, in clinical specimen of breast cancer patients, the specific EMT markers, such as Vimentin, Zeb1, Twist1, β-catenin, and MMP9 showed opposite expression patterns between the CD44+CD24− phenotype and the ALDH+ phenotype [90].